US Patent Issued to Hemex Health on Sept. 15 for "Using electrophoresis for disease detection based on controlled molecular charge" (Oregon, Washington, Ohio Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,736,500, issued on Sept. 15, was assigned to Hemex Health Inc. (Portland, Ore.).

"Using electrophoresis for disease detection based on controlled molecular charge" was invented by Peter Galen (Portland, Ore.), Ariane Elizabeth Erickson (Portland, Ore.), David Richard Bell (Issaquah, Wash.), Matthew Christian Lind (Portland, Ore.), Tyler Witte (Portland, Ore.) and Umut Atakan Gurkan (Shaker Heights, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound. The charge state of the compound correlates to a total net charge of a binder c...